Nirav Niranjan Shah, MD, Medical College of Wisconsin, Milwaukee, WI, discusses a study which reviewed if using autologous transplantation (autoHCT) in relapsed diffuse large B-cell lymphoma (DLBCL) was appropriate in patients only acheiving a PET/CT positive partial remission prior to HCT in the CAR-T cell era. The study reviewed data from the Center for International Blood and Marrow Transplant Research (CIBMTR) registry. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).